SEARCH RESULTS FOR: "Tag: GILD"
REFINE YOUR SEARCH:
RECENT
Last Month(3)
ARTICLES/BLOGS
2020(19)
2019(6)
2018(8)
2017(26)
2016(38)
2015(31)
2014(16)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(11)
Analyst Update(19)
Analyst Upgrades(8)
Bernie's Content(1)
Best and Worst Stocks(1)
Buzz Stocks(18)
By the Numbers(3)
Earnings Preview(5)
Editor's Pick(3)
Expectational Analysis(2)
General(22)
Intraday Option Activity(19)
Market Recap(5)
Midday Market Check(2)
Most Active Options Update(2)
Most Active Weekly Options(2)
Opening View(13)
Quantitative Analysis(3)
Stock Market News(4)
Stocks On the Move(17)
Technical Analysis(1)
The Week Ahead(4)
Trader Content(1)

9/14/2020 1:55 PM
A number of announcements regarding buyout offers for the entirety of -- or at least a large stake in -- various companies is kicking the week off at a rapid pace today. Specifically, biotech Immunome...
9/14/2020 11:55 AM
It's been a whirlwind start to the week, with dealmaking dominating the headlines. One of the more notable is Gilead Sciences, Inc. (NASDAQ:GILD) and their acquisition of Immunomedics (IMMU) for $21 b...
8/31/2020 9:59 AM
The shares of Gilead Sciences, Inc. (NASDAQ: GILD) are up 0.4% at $65.53 at last check, after the U.S. Food and Drug Administration (FDA) expanded emergency use of remdesivir, the company's experimen...
8/14/2020 1:20 PM
Grocery store staple Kroger Co (NYSE:KR) is charging up the charts today, least seen up 2.6% at $35.49, in an effort to reclaim its mid-March peak of $36.84. The security is set to topple recent pre...
7/27/2020 3:33 PM
The shares of Gilead Sciences, Inc. (NASDAQ: GILD) are up 0.6% at $74.08 this afternoon, enjoying a 13.8% year-to-date lead. The biotech, which rose earlier this month thanks to updates on its potent...